245 related articles for article (PubMed ID: 29651411)
1.
van Griensven J; Mengesha B; Mekonnen T; Fikre H; Takele Y; Adem E; Mohammed R; Ritmeijer K; Vogt F; Adriaensen W; Diro E
Front Cell Infect Microbiol; 2018; 8():94. PubMed ID: 29651411
[No Abstract] [Full Text] [Related]
2. Antigen Detection in Urine for Noninvasive Diagnosis and Treatment Monitoring of Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients: An Exploratory Analysis from Ethiopia.
Vogt F; Mengesha B; Asmamaw H; Mekonnen T; Fikre H; Takele Y; Adem E; Mohammed R; Ritmeijer K; Adriaensen W; Melsew Y; van Griensven J; Diro E
Am J Trop Med Hyg; 2018 Oct; 99(4):957-966. PubMed ID: 30084342
[TBL] [Abstract][Full Text] [Related]
3. The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study.
Abongomera C; Diro E; de Lima Pereira A; Buyze J; Stille K; Ahmed F; van Griensven J; Ritmeijer K
PLoS Negl Trop Dis; 2018 May; 12(5):e0006527. PubMed ID: 29799869
[TBL] [Abstract][Full Text] [Related]
4. Urine antigen detection by latex agglutination test for diagnosis and assessment of initial cure of visceral leishmaniasis.
Salam MA; Khan MG; Mondal D
Trans R Soc Trop Med Hyg; 2011 May; 105(5):269-72. PubMed ID: 21353275
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal evaluation of asymptomatic Leishmania infection in HIV-infected individuals in North-West Ethiopia: A pilot study.
van Griensven J; van Henten S; Mengesha B; Kassa M; Adem E; Endris Seid M; Abdellati S; Asefa W; Simegn T; Debasu D; Bogale T; Gedamu Y; Van Den Bossche D; Adriaensen W; Van der Auwera G; Cnops L; Vogt F; Diro E
PLoS Negl Trop Dis; 2019 Oct; 13(10):e0007765. PubMed ID: 31593563
[TBL] [Abstract][Full Text] [Related]
6. Long-term Clinical Outcomes in Visceral Leishmaniasis/Human Immunodeficiency Virus-Coinfected Patients During and After Pentamidine Secondary Prophylaxis in Ethiopia: A Single-Arm Clinical Trial.
Diro E; Ritmeijer K; Boelaert M; Alves F; Mohammed R; Abongomera C; Ravinetto R; De Crop M; Fikre H; Adera C; van Loen H; Tsoumanis A; Adriaensen W; Hailu A; Griensven JV
Clin Infect Dis; 2018 Jan; 66(3):444-451. PubMed ID: 29020217
[TBL] [Abstract][Full Text] [Related]
7. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
[TBL] [Abstract][Full Text] [Related]
8. Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in Ethiopia.
Diro E; Edwards T; Ritmeijer K; Fikre H; Abongomera C; Kibret A; Bardonneau C; Soipei P; Mutinda B; Omollo R; van Griensven J; Zijlstra EE; Wasunna M; Alves F; Alvar J; Hailu A; Alexander N; Blesson S
PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007132. PubMed ID: 30789910
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a latex agglutination test (KAtex) for detection of Leishmania antigen in urine of patients with HIV-Leishmania coinfection: value in diagnosis and post-treatment follow-up.
Riera C; Fisa R; Lopez P; Ribera E; Carrió J; Falcó V; Molina I; Gállego M; Portús M
Eur J Clin Microbiol Infect Dis; 2004 Dec; 23(12):899-904. PubMed ID: 15599651
[TBL] [Abstract][Full Text] [Related]
10. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.
Sinha PK; van Griensven J; Pandey K; Kumar N; Verma N; Mahajan R; Kumar P; Kumar R; Das P; Mitra G; Flevaud L; Ferreyra C; Remartinez D; Pece M; Palma PP
Clin Infect Dis; 2011 Oct; 53(7):e91-8. PubMed ID: 21890763
[TBL] [Abstract][Full Text] [Related]
11. Performance of latex agglutination test (KAtex) in diagnosis of visceral leishmaniasis in Iran.
Ghatei MA; Hatam GR; Hossini MH; Sarkari B
Iran J Immunol; 2009 Dec; 6(4):202-7. PubMed ID: 20054108
[TBL] [Abstract][Full Text] [Related]
12. The Risk and Predictors of Visceral Leishmaniasis Relapse in Human Immunodeficiency Virus-Coinfected Patients in Ethiopia: A Retrospective Cohort Study.
Abongomera C; Diro E; Vogt F; Tsoumanis A; Mekonnen Z; Admassu H; Colebunders R; Mohammed R; Ritmeijer K; van Griensven J
Clin Infect Dis; 2017 Oct; 65(10):1703-1710. PubMed ID: 29020196
[TBL] [Abstract][Full Text] [Related]
13. Diversity and Within-Host Evolution of Leishmania donovani from Visceral Leishmaniasis Patients with and without HIV Coinfection in Northern Ethiopia.
Franssen SU; Takele Y; Adem E; Sanders MJ; Müller I; Kropf P; Cotton JA
mBio; 2021 Jun; 12(3):e0097121. PubMed ID: 34182785
[TBL] [Abstract][Full Text] [Related]
14. Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome).
Burza S; Mahajan R; Sinha PK; van Griensven J; Pandey K; Lima MA; Sanz MG; Sunyoto T; Kumar S; Mitra G; Kumar R; Verma N; Das P
PLoS Negl Trop Dis; 2014 Aug; 8(8):e3053. PubMed ID: 25101665
[TBL] [Abstract][Full Text] [Related]
15. Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil.
Cota GF; de Sousa MR; de Mendonça AL; Patrocinio A; Assunção LS; de Faria SR; Rabello A
PLoS Negl Trop Dis; 2014 Apr; 8(4):e2816. PubMed ID: 24743472
[TBL] [Abstract][Full Text] [Related]
16. Two cases of relapsed HIV-associated visceral leishmaniasis successfully treated with combination therapy.
Mastroianni A; Gaibani P; Rossini G; Vocale C; Re MC; Ravaglia G; Sambri V; Varani S
AIDS Res Ther; 2018 Dec; 15(1):27. PubMed ID: 30572924
[TBL] [Abstract][Full Text] [Related]
17. Exploring prognosis in chronic relapsing visceral leishmaniasis among HIV-infected patients: Circulating Leishmania DNA.
Cota GF; de Sousa MR; de Assis TSM; Pinto BF; Rabello A
Acta Trop; 2017 Aug; 172():186-191. PubMed ID: 28501450
[TBL] [Abstract][Full Text] [Related]
18. Development and comparative evaluation of two antigen detection tests for Visceral Leishmaniasis.
Vallur AC; Tutterrow YL; Mohamath R; Pattabhi S; Hailu A; Abdoun AO; Ahmed AE; Mukhtar M; Salam MA; Almeida ML; Almeida RP; Mondal D; Albertini A; Ghalib H; Duthie MS; Reed SG
BMC Infect Dis; 2015 Sep; 15():384. PubMed ID: 26395447
[TBL] [Abstract][Full Text] [Related]
19. A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection.
Ritmeijer K; Dejenie A; Assefa Y; Hundie TB; Mesure J; Boots G; den Boer M; Davidson RN
Clin Infect Dis; 2006 Aug; 43(3):357-64. PubMed ID: 16804852
[TBL] [Abstract][Full Text] [Related]
20. Does timing of antiretroviral treatment influence treatment outcomes of visceral leishmaniasis in Northwest Ethiopia?
Aderie EM; Diro E; Zachariah R; da Fonseca MS; Abongomera C; Dolamo BL; Ritmeijer K
Trans R Soc Trop Med Hyg; 2017 Mar; 111(3):107-116. PubMed ID: 28633331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
